NCT05750706Completed
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Prospective Observational Study on Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Source: ClinicalTrials.gov · Last updated 6 May 2026
Brief summary (registry, in English)
The study aims to evaluate incidence of invasive antifungal infections among patients with acute lymphoblastic leukemia Ph negative during the first weeks of treatment
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 20 Feb 2023
- Start date
- 1 Jun 2022
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Acute lymphoblastic leukaemia
- NCT number
- NCT05750706
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 1 Jun 2022 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- diagnosis of acute lymphoblastic leukemia Ph positive
- acute lymphoblastic leukemia relapsed/refractory
- lymphoblastic lymphoma
Who the study is looking for
- diagnosis of acute lymphoblastic leukemia Ph negative
- age more than 18 yo
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario A. Gemelli IRCCS Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.